Cargando…

Emerging Targets in Type 2 Diabetes and Diabetic Complications

Type 2 diabetes is a metabolic, chronic disorder characterized by insulin resistance and elevated blood glucose levels. Although a large drug portfolio exists to keep the blood glucose levels under control, these medications are not without side effects. More importantly, once diagnosed diabetes is...

Descripción completa

Detalles Bibliográficos
Autores principales: Demir, Sevgican, Nawroth, Peter P., Herzig, Stephan, Ekim Üstünel, Bilgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456215/
https://www.ncbi.nlm.nih.gov/pubmed/34319011
http://dx.doi.org/10.1002/advs.202100275
_version_ 1784570829076430848
author Demir, Sevgican
Nawroth, Peter P.
Herzig, Stephan
Ekim Üstünel, Bilgen
author_facet Demir, Sevgican
Nawroth, Peter P.
Herzig, Stephan
Ekim Üstünel, Bilgen
author_sort Demir, Sevgican
collection PubMed
description Type 2 diabetes is a metabolic, chronic disorder characterized by insulin resistance and elevated blood glucose levels. Although a large drug portfolio exists to keep the blood glucose levels under control, these medications are not without side effects. More importantly, once diagnosed diabetes is rarely reversible. Dysfunctions in the kidney, retina, cardiovascular system, neurons, and liver represent the common complications of diabetes, which again lack effective therapies that can reverse organ injury. Overall, the molecular mechanisms of how type 2 diabetes develops and leads to irreparable organ damage remain elusive. This review particularly focuses on novel targets that may play role in pathogenesis of type 2 diabetes. Further research on these targets may eventually pave the way to novel therapies for the treatment—or even the prevention—of type 2 diabetes along with its complications.
format Online
Article
Text
id pubmed-8456215
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84562152021-09-27 Emerging Targets in Type 2 Diabetes and Diabetic Complications Demir, Sevgican Nawroth, Peter P. Herzig, Stephan Ekim Üstünel, Bilgen Adv Sci (Weinh) Reviews Type 2 diabetes is a metabolic, chronic disorder characterized by insulin resistance and elevated blood glucose levels. Although a large drug portfolio exists to keep the blood glucose levels under control, these medications are not without side effects. More importantly, once diagnosed diabetes is rarely reversible. Dysfunctions in the kidney, retina, cardiovascular system, neurons, and liver represent the common complications of diabetes, which again lack effective therapies that can reverse organ injury. Overall, the molecular mechanisms of how type 2 diabetes develops and leads to irreparable organ damage remain elusive. This review particularly focuses on novel targets that may play role in pathogenesis of type 2 diabetes. Further research on these targets may eventually pave the way to novel therapies for the treatment—or even the prevention—of type 2 diabetes along with its complications. John Wiley and Sons Inc. 2021-07-28 /pmc/articles/PMC8456215/ /pubmed/34319011 http://dx.doi.org/10.1002/advs.202100275 Text en © 2021 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Demir, Sevgican
Nawroth, Peter P.
Herzig, Stephan
Ekim Üstünel, Bilgen
Emerging Targets in Type 2 Diabetes and Diabetic Complications
title Emerging Targets in Type 2 Diabetes and Diabetic Complications
title_full Emerging Targets in Type 2 Diabetes and Diabetic Complications
title_fullStr Emerging Targets in Type 2 Diabetes and Diabetic Complications
title_full_unstemmed Emerging Targets in Type 2 Diabetes and Diabetic Complications
title_short Emerging Targets in Type 2 Diabetes and Diabetic Complications
title_sort emerging targets in type 2 diabetes and diabetic complications
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456215/
https://www.ncbi.nlm.nih.gov/pubmed/34319011
http://dx.doi.org/10.1002/advs.202100275
work_keys_str_mv AT demirsevgican emergingtargetsintype2diabetesanddiabeticcomplications
AT nawrothpeterp emergingtargetsintype2diabetesanddiabeticcomplications
AT herzigstephan emergingtargetsintype2diabetesanddiabeticcomplications
AT ekimustunelbilgen emergingtargetsintype2diabetesanddiabeticcomplications